Public Comment Received by Advisory Group on Organizational Guidelines
in Response to Request for Public Comment
(March 19, 2002)

American Bar Association, Antitrust Section (June 27, 2002)

Sideman & Bancroft, David P. Bancroft, Esq. (May 23, 2002)

Arnold & Porter, John T. Bentivoglio, Esq. and PriceWaterHouseCoopers, Brent L. Saunders, on behalf of 18 pharmaceutical companies (May 20, 2002)

Coalition for Ethics & Compliance Initiatives (CECI), Jay M. Cohen (May 20, 2002)

de la Parte & Gilbert, P.A., Ronald A. Christaldi (May 20, 2002)

Ethics & Policy Integration, Kenneth W. Johnson (May 20, 2002)

Ethics Resource Center, Stuart Gilman (May 20, 2002)

Hale and Dorr LLP, Kenneth R. Meade, Esq., on behalf of Corporate Environmental Enforcement Counsel (May 20, 2002)

PriceWaterhouseCoopers LLP, Barbara H. Kipp (May 20, 2002)

Sidley Austin Brown & Wood LLP, David T. Buente, Esq. and Christopher Bell, Esq., on behalf of the American Chemical Council (May 20, 2002)

The Regence Group, Rosemary Reeve and Randall L. Romrell, on behalf of Blue Cross/Blue Shield plans in Northwest and Mountain States (May 20, 2002)

U.S. Office of Government Ethics, Amy Comstock (May 20, 2002)

Washington Legal Foundation (May 20, 2002)

Ethical Leadership Group, Steven Priest (May 16, 2002)

Johnson & Johnson, Roger S. Fine (May 16, 2002)

Stewart & Stevenson, Kevin Teismann, (May 16, 2002)

Alliance for Health Care Integrity, Robert Olson, PhD, MPH (May 15, 2002)

LR Solutions, Ray Nussbaum (May 8, 2002)